Skip to main content
Real-World Evidence Solutions Market Analysis Americas, EMEA, APAC - US, UK, Germany, France, Japan - Size and Forecast 2020-2024

Real-World Evidence Solutions Market Analysis Americas, EMEA, APAC - US, UK, Germany, France, Japan - Size and Forecast 2020-2024

Published: Aug 2020 120 Pages SKU: IRTNTR41122

Real-World Evidence Solutions Market Analysis Report 2020-2024:

The real-world evidence solutions market size has the potential to grow by USD 697.92 mn during 2020-2024, and the market’s growth momentum will accelerate during the forecast period.

This report provides a detailed analysis of the market by market landscape (oncology, immunology, cardiology, neurology, and others) and geography (Americas, EMEA, and APAC). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Clinigen Group Plc, ICON Plc, International Business Machines Corp., IQVIA Inc., Laboratory Corp. of America Holdings, Parexel International Corp., PerkinElmer Inc., Pharmaceutical Product Development LLC, SAS Institute Inc., and and Syneos Health Inc.

Market Overview

Real-World-Evidence-Solutions-Market-Market-Size-2019-2024

Browse TOC and LoE with selected illustrations and example pages of Real-World Evidence Solutions Market

Request a FREE sample now!

Market Competitive Analysis

The market is fragmented. Clinigen Group Plc, ICON Plc, International Business Machines Corp., IQVIA Inc., Laboratory Corp. of America Holdings, Parexel International Corp., PerkinElmer Inc., Pharmaceutical Product Development LLC, SAS Institute Inc., and and Syneos Health Inc. are some of the major market participants. Factors such as benefits of real-world evidence solutions will offer immense growth opportunities. To make the most of the opportunities, vendors should focus on growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this real-world evidence solutions market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this real-world evidence solutions market analysis report provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading companies, including:

  • Clinigen Group Plc
  • ICON Plc
  • International Business Machines Corp.
  • IQVIA Inc.
  • Laboratory Corp. of America Holdings
  • Parexel International Corp.
  • PerkinElmer Inc.
  • Pharmaceutical Product Development LLC
  • SAS Institute Inc.
  • and Syneos Health Inc.

 

Real-World Evidence Solutions Market: Segmentation by Geography

Real-World-Evidence-Solutions-Market-Market-Share-by-Region-2019-2024

For more insights on the market share of various regions Request for a FREE sample now!

The report offers an up-to-date analysis regarding the current Global market scenario, latest trends and drivers, and the overall market environment. Americas will offer several growth opportunities to market vendors during the forecast period. The integration of ehrs with electronic data collection systems will significantly influence real-world evidence solutions market's growth in this region.

52% of the market’s growth will originate from Americas during the forecast period. The US is the key market for real-world evidence solutions market  in Americas. This report provides an accurate prediction of the contribution of all segments to the growth of the real-world evidence solutions market size.

Real-World Evidence Solutions Market: Key Highlights of the Report for 2020-2024

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that will real-world evidence solutions market growth during the next five years
  • Precise estimation of the real-world evidence solutions market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the real-world evidence solutions industry across Americas, EMEA, and APAC
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of real-world evidence solutions market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Real-World Evidence Solutions Market Scope

Report Coverage

Details

Page number

120

Base year

2019

Forecast period

2020-2024

Growth momentum & CAGR

Accelerate at a CAGR of 13%

Market growth 2020-2024

USD 697.92 million

Market structure

Fragmented

YoY growth (%)

10.53

Regional analysis

Americas, EMEA, and APAC

Performing market contribution

Americas at 52%

Key consumer countries

US, UK, Germany, France, and Japan

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Clinigen Group Plc, ICON Plc, International Business Machines Corp., IQVIA Inc., Laboratory Corp. of America Holdings, Parexel International Corp., PerkinElmer Inc., Pharmaceutical Product Development LLC, SAS Institute Inc., and and Syneos Health Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Real-World Evidence Solutions market growth will increase by 697.92 million during 2019-2024.

The Real-World Evidence Solutions market is expected to grow at a CAGR of 12.93% during 2019-2024.

Real-World Evidence Solutions market is segmented by Other 1( Oncology, Immunology, Cardiology, Neurology, Others) Other 1( Lead generation, Brand awareness, Thought leadership, Others) Geographic( Americas, EMEA, APAC)

Clinigen Group Plc, ICON Plc, International Business Machines Corp., IQVIA Inc., Laboratory Corp. of America Holdings, Parexel International Corp., PerkinElmer Inc., Pharmaceutical Product Development LLC, SAS Institute Inc., Syneos Health Inc. are a few of the key vendors in the Real-World Evidence Solutions market.

Americas will register the highest growth rate of 52.35% among the other regions. Therefore, the Real-World Evidence Solutions market in Americas is expected to garner significant business opportunities for the vendors during the forecast period.

US, UK, Germany, France, Japan

  • Benefits of real-world evidence solutions is the driving factor this market.

The Real-World Evidence Solutions market vendors should focus on grabbing business opportunities from the Oncology segment as it accounted for the largest market share in the base year.